Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Brooks Laboratories Ltd

BROOKS.NS ✓ COMPLIANT ☆ Track — members

NSE India · Healthcare · Pharmaceuticals ·

India Micro Cap Analyst: N/A

Last Close

$0.65

▼ -4.86%

Market Cap $19.26M · Vol 34.22K

Key Metrics

P/E Ratio

7.47

FWD: N/A

Market Cap

$19.26M

Micro Cap

Div Yield

N/A

EPS Growth

N/A

YoY

RSI (14)

45.48

Momentum

Beta

2.09

vs Market

52W High

$1.72

64.85% below

52W Low

$0.38

69.97% above

Volume

34.22K

Avg 24.28K

P/B

N/A

Price-to-book

ROE

N/A

Return on equity

Free Float

44.12%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Brooks Laboratories Ltd (BROOKS.NS) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does BROOKS.NS pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+4.00%

-9.93%

+30.02%

-17.68%

YTD

-22.12%

-58.59%

-48.08%

-50.19%

Financials & Valuation

TTM · Annual

Total Revenue	$9.17M
Net Income	$2.63M
Revenue Growth (YoY)	-10.00%
Gross Margin	38.64%
Operating Margin	6.38%
Net Profit Margin	N/A
ROE	N/A
ROA · ROIC	18.08% · N/A

P/E Ratio	7.47
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	N/A
P/B	N/A
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	29.46M

Technical Indicators

50-Day SMA	$0.70
200-Day SMA	$0.76
RSI (14)	45.48
Beta	2.09
52-Week High	$1.72
52-Week Low	$0.38

Volume Today	34.22K
Avg Daily Volume (30D)	24.28K
Relative Volume	1.41x
Volatility (10D)	42.98
Volatility (30D)	37.08
Free Float	44.12%

Analyst Consensus

N/A

Current Price $0.65

Mean Target N/A

52W Low$0.38 52W High$1.72

Current

Target

$0.38 $1.72

Current Analyst target

· 0 analysts

Identifiers

ExchangeNSE India

FIGIBBG001TG4DR8

ISININE650L01011

CountryIndia

Sub-IndustryGeneric Pharmaceuticals

Earnings DateN/A

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

SUNPHARMA.NS Sun Pharmaceutical Industries Ltd -0.10% 4578.T Otsuka Holdings Co Ltd -3.26% CIPLA.NS Cipla Ltd -0.60% ZYDUSLIFE.NS Zydus Lifesciences Ltd -2.75% RICHTER.BU Richter Gedeon Vegyeszeti Gyar Nyrt +1.56%

Company Profile

Brooks Laboratories Limited is an India-based pharmaceutical manufacturing company working on a contract basis. The Company’s segment is Pharmaceutical products, including ingredients and intermediaries. It manufactures various pharmaceutical dosage forms, including injections, tablets, dry syrup, and eye/ear drops. Its products under the Carbapenem category are Imipenem 250 (Milligram) mg + Cilastatin 250mg, Imipenem 500mg + Cilastatin 500mg, Meropenem 250mg, Meropenem 500mg, Meropenem 1000mg+Sulbactam 500mg, Meropenem 1000mg+Tazobactam 500mg, and Doripenem 500mg. It offers Penicillins in the form of injections, tablets, and dry syrup. Its general category of products includes liquid injections, dry powder injections and eye/ear drops. Its liquid injections include Iron sucrose 100mg/5ml, Iron sucrose 50mg/2.5ml, Phenytoin sodium 50mg/ml and others. Its dry powder injections include Artesunate 60mg, Artesunate 120mg, Omeprazole 40mg, Rabeprazole 20mg, Pantoprazole 40mg and others.